Clinical Protocol REN-007E - Extension Study: An Evaluation of Patient Reported Outcomes and Clinical Outcomes Through 12 Months Post-Cardiac Surgery in Patients Enrolled in Study REN-007
Latest Information Update: 01 Apr 2025
At a glance
- Drugs Iron-sucrose/tin-protoporphyrin (Primary)
- Indications Postoperative complications
- Focus Adverse reactions; Therapeutic Use
- Sponsors Renibus Therapeutics
- 15 Nov 2023 Status changed from not yet recruiting to recruiting.
- 26 Oct 2023 New trial record